Medios AG (0QB4.L) LSE
12.90
-0.36(-2.71%)
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
12.90
-0.36(-2.71%)
Currency In EUR
Sector
Healthcare
Industry
Medical - Distribution
Employees
472
First IPO Date
November 07, 2017
| Name | Title | Pay | Year Born |
| Thomas Meier | CEO & Member of Executive Board | 0 | 1968 |
| Falk Neukirch | Executive Officer | 579,000 | 1971 |
| Christoph Prusseit | Chief Business Officer of Germany & Member of Executive Board | 589,000 | 1988 |
| Constantijn van Rietschoten | Chief Business Officer of International and Member of Executive Board | 589,000 | 1970 |
| Claudia Nickolaus | Head of Investor & Public Relations | 0 | N/A |
| Stefan Bauerreis | CFO & Member of the Executive Board | 0 | 1972 |
Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.